Find a Specialist by Postal Code | Page 7 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Ellen Ritchie, MD The New York Presbyterian Hospital New York City New York United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Suneet Agarwal, MD, PhD Boston's Children's Hospital Boston Massachusetts United States
  • Aplastic Anemia
  • Pediatric
Elie Traer, MD, PhD OHSU Knight Cancer Institute Beaverton Oregon United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Joshua Sasine, MD, PhD Ronald Reagan UCLA Medical Center Los Angeles California United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Krishna Gundabolu, MBBS Fred and Pamela Buffett Cancer Center Omaha Nebraska United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
David Margolis, MD Children’s Hospital of Wisconsin Milwaukee Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric
Krisstina Gowin, DO University of Arizona Tucson Arizona United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Karamjeet Singh Sandhu, MD City of Hope Duarte California United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Michael Savona, MD Vanderbilt University Medical Center Malignant Hematology Clinic Nashville Tennessee United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Tapan M. Kadia, MD MD Anderson Cancer Center Houston Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
Anthony Hunter, MD Winship Cancer Institute of Emory University Atlanta Georgia United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Leslie Ellis, BS, MD Wake Forest Baptist Health Comprehensive Cancer Center Winston-Salem North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Hemant Murthy, MD Mayo Clinic - Jacksonville Jacksonville Florida United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Mikhail Kogan, MD George Washington Center for Integrative Medicine Washington DC District Of Columbia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Bart Scott, MD Fred Hutchinson Cancer Research Center Seattle Washington United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Carlos DeCastro, MD Duke University Medical Center Durham North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Richard M. Stone, MD Dana-Farber Cancer Institute Boston Massachusetts United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Celalettin Ustun, MD Rush University Chicago Illinois United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
Catherine Broome, MD MedStar Health - Georgetown Washington District Of Columbia United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Jill de Jong, MD, PhD University of Chicago Medicine, Comer Children's Hospital Chicago Illinois United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Pediatric